Early diagnosis of reactive infectious mucocutaneous eruption is important to minimize potential long-term disease ...

Armata Pharmaceuticals Announces Third Quarter 2025 Results And Provides Corporate Update. LOS ANGELES, Nov. 12, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (Armata or the ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused ...

Antimicrobial resistance (AMR) causes over 35,000 deaths annually in the EU/EEA and is projected to result in 1.91 million ...

Mycoplasma pneumoniae infections have risen significantly post-COVID-19, presenting with both respiratory and increasing non-respiratory symptoms, including dermatologic and neurologic manifestations.

A 76-year-old man on dabigatran for rate-controlled atrial fibrillation had follow-up transthoracic echocardiography (TTE) ...

Invisible, toxic fungi in animal feed can slash livestock productivity, weaken immunity, and pose serious health risks to ...

ClearPoint Neuro, Inc. ( CLPT) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST [Audio Gap] comments made on this call may include statements that are forward-looking within the meaning of ...

Speaking at the Veterinary Ireland conference, Damien Barrett, Head of the Ruminant Animal Health Programme Division at the ...

Atea defines working capital as current assets less current liabilities. See the Company’s condensed consolidated financial statements in its Quarterly Report on Form 10-Q for the three months ended ...

A group of healthcare societies has issued updated infection control guidance for nursing homes, marking the guideline’s first update in 17 years. The guidance was published Oct. 28 in Infection ...

Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...